SYNDAX PHARMACEUTICALS INC (SNDX) Stock Earnings & Estimates
NASDAQ:SNDX - US87164F1057 - Common Stock
15.66 USD
-0.58 (-3.57%)
16 USD
+0.34 (+2.17%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 23.68M | 162.38M 585.73% | 315.29M 94.17% | 431.54M 36.87% | 596.7M 38.27% | 732.84M 22.82% | 904.2M 23.38% | 1.003B 10.93% | 1.128B 12.46% | ||
| EBITDA YoY % growth | -151.77M -678.39% | -229.942M -51.51% | -339.664M -47.72% | -316.807M 6.73% | -195.417M 38.32% | -107.475M 45.00% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -151.8M -679.39% | -229.954M -51.48% | -339.672M -47.71% | -313.264M 7.77% | -203.303M 35.10% | -111.894M 44.96% | 64.838M 157.95% | 164.63M 153.91% | 296.58M 80.15% | 333.74M 12.53% | 434.32M 30.14% | |
| Operating Margin | N/A | N/A | -1,434.43% | -192.92% | -64.48% | -25.93% | 10.87% | 22.46% | 32.80% | 33.27% | 38.50% | |
| EPS YoY % growth | -2.45 -669.77% | -2.96 -20.82% | -3.73 -26.01% | -3.28 12.16% | -1.90 41.93% | -1.00 47.17% | 0.78 177.13% | 1.65 112.50% | 2.85 72.76% | 3.15 10.75% | 3.92 24.27% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.75 23.10% | -0.66 39.72% | -0.70 28.18% | -0.64 22.58% | -0.58 22.85% | -0.52 21.55% |
| Revenue Q2Q % growth | 45.22M 261.76% | 58.233M 658.24% | 60.078M 199.76% | 67.371M 77.49% | 71.298M 57.67% | 79.968M 37.32% |
| EBITDA Q2Q % growth | -63.698M 28.88% | -53.672M 44.30% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -68.015M 24.07% | -60.843M 36.86% | -54.422M 34.83% | -50.391M 27.34% | -43.758M 35.66% | -36.924M 39.31% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.83 -3.75% | -1.04 | 0.21 | 19.92% |
| Q1 2025 Q2Q % growth | -0.98 -15.29% | -1.36 | 0.38 | 27.80% |
| Q4 2024 Q2Q % growth | -1.10 -10.00% | -0.23 | -0.87 | -370.62% |
| Q3 2024 Q2Q % growth | -0.98 -34.25% | -1.14 | 0.16 | 13.67% |
| Q2 2024 Q2Q % growth | -0.80 -25.00% | -0.93 | 0.13 | 14.20% |
| Q1 2024 Q2Q % growth | -0.85 -44.07% | -1.00 | 0.15 | 14.84% |
| Q4 2023 Q2Q % growth | -1.00 -61.29% | -1.01 | 0.01 | 1.39% |
| Q3 2023 Q2Q % growth | -0.73 -25.86% | -0.81 | 0.08 | 10.03% |
| Q2 2023 Q2Q % growth | -0.64 -3.23% | -0.75 | 0.11 | 14.31% |
| Q1 2023 Q2Q % growth | -0.59 6.35% | -0.61 | 0.02 | 2.90% |
| Q4 2022 Q2Q % growth | -0.62 -134.25% | -0.66 | 0.04 | 6.31% |
| Q3 2022 Q2Q % growth | -0.58 -45.00% | -0.65 | 0.07 | 10.45% |
| Q2 2022 Q2Q % growth | -0.62 -40.91% | -0.65 | 0.03 | 4.53% |
| Q1 2022 Q2Q % growth | -0.63 -16.67% | -0.65 | 0.02 | 2.73% |
| Q4 2021 Q2Q % growth | 1.81 511.36% | 0.28 | 1.53 | 537.56% |
| Q3 2021 Q2Q % growth | -0.40 13.04% | -0.24 | -0.16 | -69.27% |
| Q2 2021 Q2Q % growth | -0.44 -4.76% | -0.73 | 0.29 | 39.67% |
| Q1 2021 Q2Q % growth | -0.54 3.57% | -0.66 | 0.12 | 18.34% |
| Q4 2020 Q2Q % growth | -0.44 | -0.50 | 0.06 | 11.33% |
| Q3 2020 Q2Q % growth | -0.46 -12.20% | -0.45 | -0.01 | -3.12% |
| Q2 2020 Q2Q % growth | -0.42 10.64% | -0.45 | 0.03 | 7.64% |
| Q1 2020 Q2Q % growth | -0.56 -5.66% | -0.52 | -0.04 | -6.99% |
| Q4 2019 Q2Q % growth | -0.44 | -0.43 | -0.01 | -1.43% |
| Q3 2019 Q2Q % growth | -0.41 | -0.48 | 0.07 | 14.61% |
| Q2 2019 Q2Q % growth | -0.47 | -0.44 | -0.03 | -7.53% |
| Q1 2019 Q2Q % growth | -0.53 | -0.57 | 0.04 | 6.40% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 37.958M 984.51% | 27.361M | 10.597M | 38.73% |
| Q1 2025 Q2Q % growth | 20.042M | 14.722M | 5.32M | 36.14% |
| Q4 2024 Q2Q % growth | 7.68M | 87.63M | -79.95M | -91.24% |
| Q3 2024 Q2Q % growth | 12.5M | 11.423M | 1.077M | 9.43% |
| Q1 2023 Q2Q % growth | 437.141K | -437.141K | -100.00% | |
| Q4 2022 Q2Q % growth | -100.00% | 382.5K | -382.5K | -100.00% |
| Q3 2022 Q2Q % growth | -100.00% | 765K | -765K | -100.00% |
| Q2 2022 Q2Q % growth | -100.00% | 1.403M | -1.403M | -100.00% |
| Q1 2022 Q2Q % growth | -100.00% | 2.173M | -2.173M | -100.00% |
| Q4 2021 Q2Q % growth | 126.6M 31,550.00% | 59.854M | 66.746M | 111.51% |
| Q3 2021 Q2Q % growth | 12.4M 3,000.00% | 29.937M | -17.537M | -58.58% |
| Q2 2021 Q2Q % growth | 400K | 183.6K | 216.4K | 117.86% |
| Q1 2021 Q2Q % growth | 400K | 229.5K | 170.5K | 74.29% |
| Q4 2020 Q2Q % growth | 400K | 204K | 196K | 96.08% |
| Q3 2020 Q2Q % growth | 400K | 306K | 94K | 30.72% |
| Q2 2020 Q2Q % growth | 400K | 408K | -8K | -1.96% |
| Q1 2020 Q2Q % growth | 400K | 860.033K | -460.033K | -53.49% |
| Q4 2019 Q2Q % growth | 400K | 379.032K | 20.968K | 5.53% |
| Q3 2019 Q2Q % growth | 400K | 379.032K | 20.968K | 5.53% |
| Q2 2019 Q2Q % growth | 400K | 383.857K | 16.143K | 4.21% |
| Q1 2019 Q2Q % growth | 400K | 371.79K | 28.21K | 7.59% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 21.05% | 25.96% | 16.82% | 12.61% |
| Revenue | 33.46% | 76.74% | 29.12% | 58.11% |